Cargando…
Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
Autores principales: | Holien, Toril, Misund, Kristine, Olsen, Oddrun Elise, Baranowska, Katarzyna Anna, Buene, Glenn, Børset, Magne, Waage, Anders, Sundan, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267601/ https://www.ncbi.nlm.nih.gov/pubmed/30542518 http://dx.doi.org/10.18632/oncotarget.26373 |
Ejemplares similares
-
MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015) -
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
por: Baranowska, Katarzyna, et al.
Publicado: (2016) -
Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012) -
Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017) -
Identification of the source of elevated hepatocyte growth factor levels in multiple myeloma patients
por: Rampa, Christoph, et al.
Publicado: (2014)